Inflammatory Responses to Amyloidosis in a Transgenic Mouse Model of Alzheimer’s Disease
Authors:
- Melanie PiccianoMPMelanie Picciano
- Brian MalesterBMBrian Malester
- John LaFrancoisJLJohn LaFrancois
- Cindy ZehrCZCindy Zehr
- JoAnna M. DaeschnerJDJoAnna M. Daeschner
- John A. OlschowkaJOJohn A. Olschowka
- Maria I. FonsecaMFMaria I. Fonseca
- M. Kerry O’banionM. Kerry O’banion
- Andrea J. TennerATAndrea J. Tenner
- Karen DuffKaren Duff
- 1 April 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (4) , 1345-1354
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS 33553, NIH AG-16573, AG-172116)
This publication has 33 references indexed in Scilit:
- MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASESAnnual Review of Neuroscience, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease ProgressionBrain Pathology, 1998
- Expression and Regulation of Cyclooxygenase‐2 in Rat MicrogliaEuropean Journal of Biochemistry, 1997
- Modulation of immune cell function by the autonomic nervous systemPharmacology & Therapeutics, 1997
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996
- β-Amyloid converts an acute phase injury response to chronic injury responsesNeurobiology of Aging, 1996
- Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaquesNeuron, 1995
- Tau protein and the neurofibrillary pathology of Alzheimer's diseaseTrends in Neurosciences, 1993